Biotech1 year ago
AbolerIS Pharma Closes a Round of €27 Million Led by Caixa Capital
AbolerIS Pharma is a biopharmaceutical company focused on revolutionizing immunotherapy for autoimmune and inflammatory diseases. Through an innovative antibody therapy directed against the novel target CD45RC,...